High Dose IL 2 and Entinostat in RCC

Clinical trial NCT03501381 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03501381
Sponsor: Roberto Pili
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Renal Cell Carcinoma

Start date: 2018-05-24
Primary completion: 2023-01-20
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.